Sio Capital Management as of June 30, 2026
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 59 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Anteris Technologies Global (AVR) | 9.0 | $55M | 5.5M | 9.85 | |
| AmerisourceBergen (COR) | 8.1 | $49M | 174k | 282.98 | |
| Maximus (MMS) | 6.4 | $39M | 715k | 53.76 | |
| Allogene Therapeutics (ALLO) | 4.6 | $28M | 13M | 2.08 | |
| Globus Med Cl A (GMED) | 3.9 | $24M | 302k | 79.01 | |
| GSK Sponsored Adr (GSK) | 3.8 | $23M | 437k | 52.42 | |
| Tyra Biosciences (TYRA) | 3.7 | $22M | 695k | 31.94 | |
| Waystar Holding Corp (WAY) | 3.1 | $19M | 926k | 20.53 | |
| Sellas Life Sciences Group I Com New Put Option (SLS) | 3.0 | $18M | 1.2M | 14.76 | |
| Ideaya Biosciences (IDYA) | 3.0 | $18M | 480k | 37.27 | |
| Oruka Therapeutics (ORKA) | 2.8 | $17M | 177k | 95.17 | |
| Cigna Corp (CI) | 2.6 | $16M | 58k | 275.68 | |
| Sanofi Sa Sponsored Adr (SNY) | 2.6 | $16M | 364k | 42.66 | |
| Icon Pub SHS (ICLR) | 2.5 | $15M | 88k | 173.71 | |
| Viatris (VTRS) | 2.5 | $15M | 954k | 15.88 | |
| Cross Country Healthcare (CCRN) | 2.4 | $15M | 1.1M | 13.21 | |
| Rapport Therapeutics (RAPP) | 2.1 | $13M | 308k | 41.67 | |
| Abbott Laboratories (ABT) | 1.9 | $12M | 129k | 90.74 | |
| Celcuity (CELC) | 1.9 | $12M | 110k | 104.62 | |
| Zimmer Holdings (ZBH) | 1.9 | $11M | 131k | 86.09 | |
| Regeneron Pharmaceuticals (REGN) | 1.9 | $11M | 18k | 623.54 | |
| Bristol Myers Squibb (BMY) | 1.8 | $11M | 194k | 57.62 | |
| Medtronic SHS (MDT) | 1.8 | $11M | 143k | 78.23 | |
| Vir Biotechnology (VIR) | 1.8 | $11M | 1.1M | 10.19 | |
| Senseonics Hldgs (SENS) | 1.5 | $9.0M | 1.6M | 5.68 | |
| Eyepoint Com New (EYPT) | 1.5 | $8.9M | 623k | 14.30 | |
| Cybin Com New (HELP) | 1.4 | $8.6M | 1.3M | 6.61 | |
| Biosante Pharmaceuticals (ANIP) | 1.3 | $8.1M | 97k | 82.78 | |
| Protara Therapeutics Com Stk (TARA) | 1.2 | $7.3M | 1.9M | 3.82 | |
| Relmada Therapeutics (RLMD) | 1.1 | $6.9M | 1.0M | 6.92 | |
| Tango Therapeutics (TNGX) | 1.1 | $6.5M | 209k | 31.26 | |
| Aquestive Therapeutics (AQST) | 1.0 | $6.2M | 1.5M | 4.16 | |
| Dianthus Therapeutics (DNTH) | 1.0 | $5.8M | 59k | 97.48 | |
| Sionna Therapeutics (SION) | 0.9 | $5.6M | 128k | 43.99 | |
| Ocular Therapeutix (OCUL) | 0.9 | $5.3M | 540k | 9.82 | |
| Zenas Biopharma (ZBIO) | 0.9 | $5.3M | 209k | 25.38 | |
| Bright Minds Biosciences Com New (DRUG) | 0.9 | $5.2M | 74k | 70.20 | |
| Onkure Therapeutics Com Cl A (OKUR) | 0.8 | $4.9M | 1.1M | 4.56 | |
| Savara (SVRA) | 0.6 | $3.8M | 618k | 6.16 | |
| Pmv Pharmaceuticals (PMVP) | 0.6 | $3.5M | 2.6M | 1.34 | |
| Aveanna Healthcare Hldgs (AVAH) | 0.5 | $3.2M | 369k | 8.57 | |
| Ovid Therapeutics (OVID) | 0.4 | $2.7M | 1.0M | 2.69 | |
| Immunome (IMNM) | 0.4 | $2.6M | 124k | 21.19 | |
| Hims & Hers Health Com Cl A Call Option (HIMS) | 0.4 | $2.6M | 75k | 34.67 | |
| An2 Therapeutics (ANTX) | 0.4 | $2.6M | 530k | 4.84 | |
| Serina Therapeutics Com Shs (SER) | 0.3 | $1.9M | 1.0M | 1.94 | |
| Aligos Therapeutics Com New (ALGS) | 0.3 | $1.9M | 327k | 5.77 | |
| Ibio Com New (IBIO) | 0.3 | $1.6M | 904k | 1.75 | |
| Xilio Therapeutics (XLO) | 0.2 | $1.5M | 153k | 9.58 | |
| CryoLife (AORT) | 0.2 | $1.1M | 49k | 22.47 | |
| Bridgebio Oncology Therapeut Com New (BBOT) | 0.2 | $995k | 131k | 7.62 | |
| Tela Bio (TELA) | 0.1 | $477k | 636k | 0.75 | |
| Adagio Med Hldgs (ADGM) | 0.1 | $456k | 699k | 0.65 | |
| NeuroOne Medical Technologies Corporat (NMTC) | 0.0 | $252k | 83k | 3.04 | |
| Enveric Biosciences Com Shs (ENVB) | 0.0 | $248k | 180k | 1.38 | |
| Modular Med Com New (MODD) | 0.0 | $118k | 26k | 4.50 | |
| Qt Imaging Hldgs (QTI) | 0.0 | $62k | 15k | 4.07 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $1.5k | 400k | 0.00 | |
| Humacyte *w Exp 08/27/202 (HUMAW) | 0.0 | $474.981000 | 50k | 0.01 |
